Leukocyte telomere length and renal cell carcinoma survival in two studies

BACKGROUND: Leukocyte telomere length (LTL) is a potential biomarker of cancer prognosis; however, evidence for renal cell carcinoma (RCC) is inconsistent. METHODS: We investigated LTL and RCC-specific survival among 684 cases from the US kidney cancer study (USKC) and 241 cases from the prostate, l...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Br J Cancer
Glavni autori: Callahan, Catherine L, Schwartz, Kendra, Ruterbusch, Julie J, Shuch, Brian, Graubard, Barry I, Lan, Qing, Cawthon, Richard, Baccarelli, Andrea A, Chow, Wong-Ho, Rothman, Nathaniel, Hofmann, Jonathan N, Purdue, Mark P
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2017
Teme:
Epidemiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572185/
https://ncbi.nlm.nih.gov/pubmed/28742796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.237
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items